Aug 13, 2026 08:31AM
Aug 13, 2026 08:30AM
Aug 11, 2026 08:31AM
Aug 11, 2026 08:30AM
Jul 30, 2026 08:30AM
Jul 30, 2026 08:30AM
Jul 2, 2026 08:30AM Cingulate added to Russell 3000E index
Jul 2, 2026 08:30AM
Jun 16, 2026 08:02AM
Jun 16, 2026 08:00AM
Jun 4, 2026 04:48PM
Jun 2, 2026 08:01AM
Jun 2, 2026 08:00AM
May 26, 2026 06:59AM H.C. Wainwright Reiterates Buy Rating on Cingulate (CING)
May 14, 2026 08:03AM
May 14, 2026 08:00AM
Apr 6, 2026 04:34PM
Mar 18, 2026 08:00AM
Feb 17, 2026 08:02AM
Feb 17, 2026 08:00AM
Nov 18, 2025 04:27PM Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 3Q25
Nov 13, 2025 08:00AM
Nov 10, 2025 08:01AM
Nov 10, 2025 08:00AM
Oct 28, 2025 08:01AM
Oct 28, 2025 08:00AM
Oct 23, 2025 04:45PM
Oct 14, 2025 08:04AM FDA accepts Cingulate's drug application for ADHD treatment CTx-1301
Oct 14, 2025 08:00AM
Sep 17, 2025 08:45AM
Sep 17, 2025 08:45AM
Aug 21, 2025 04:35PM
Aug 19, 2025 08:45AM
Aug 15, 2025 09:02AM
Aug 15, 2025 09:00AM Cingulate Provides Management Team Update
Aug 6, 2025 08:45AM
Aug 6, 2025 08:45AM
Jul 29, 2025 08:01AM
Jul 29, 2025 08:00AM
Jul 9, 2025 08:03AM
Jul 9, 2025 08:00AM
Jun 18, 2025 08:00AM Stonegate Capital Partners Initiates Coverage on Cingulate Inc. (CING)
May 20, 2025 08:03AM
May 20, 2025 08:00AM
May 14, 2025 08:04AM
May 14, 2025 08:00AM
May 8, 2025 04:30PM
Apr 29, 2025 08:00AM
Apr 3, 2025 08:06AM Cingulate Inc (CING) Completes Pre-NDA Meeting with FDA to Discuss New Drug Application for lead ADHD Asset CTx-1301
Apr 3, 2025 08:00AM

328,440 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All